Aurinia Pharmaceuticals News

Aurinia Pharmaceuticals | 8-K: Current report

Sep 12, 2024 16:09 ET

Aurinia Pharmaceuticals | 8-K: Current report

Jun 14, 2024 17:30 ET

Aurinia Pharmaceuticals | DEFA14A: Others

Jun 4, 2024 17:29 ET

Aurinia Pharmaceuticals | DEFA14A: Others

Jun 4, 2024 14:56 ET

Aurinia Pharmaceuticals | DEFA14A: Others

May 3, 2024 16:18 ET

Aurinia Pharmaceuticals | DEF 14A: Definitive information statements

May 3, 2024 16:12 ET

Aurinia Pharmaceuticals | 8-K: Current report

Feb 29, 2024 16:15 ET

Aurinia Pharmaceuticals | 8-K: Current report

Feb 15, 2024 06:12 ET

Aurinia Pharmaceuticals | 8-K: Current report

Sep 21, 2023 16:06 ET

Aurinia Pharmaceuticals | 8-K: Current report

Aug 21, 2023 16:11 ET

Aurinia Pharmaceuticals | 8-K: Current report

Jul 3, 2023 06:06 ET

Aurinia Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

May 26, 2023 16:39 ET

Aurinia Pharmaceuticals | 8-K: Current report

May 17, 2023 16:03 ET

Aurinia Pharmaceuticals | DEFA14A: Others

May 8, 2023 16:04 ET

Aurinia Pharmaceuticals | DEFA14A: Others

May 2, 2023 16:39 ET

Aurinia Pharmaceuticals | DEFA14A: Others

Apr 28, 2023 16:03 ET

Aurinia Pharmaceuticals | DEF 14A: Definitive proxy statements

Apr 18, 2023 16:24 ET

Aurinia Pharmaceuticals | 8-K: Current report

Apr 5, 2023 08:16 ET

Aurinia Pharmaceuticals | 8-K: Current report

Mar 13, 2023 06:03 ET

Aurinia Pharmaceuticals | 8-K: Current report

Jan 27, 2023 16:07 ET